Michael Petusky

Stock Analyst at Barrington Research

(2.29)
# 2,651
Out of 5,106 analysts
213
Total ratings
41.88%
Success rate
-1.83%
Average return

Stocks Rated by Michael Petusky

DENTSPLY SIRONA
Dec 16, 2025
Maintains: Outperform
Price Target: $14
Current: $11.08
Upside: +26.35%
Merit Medical Systems
Nov 14, 2025
Maintains: Outperform
Price Target: $106
Current: $87.63
Upside: +20.96%
Haemonetics
Nov 7, 2025
Maintains: Outperform
Price Target: $86$90
Current: $80.36
Upside: +12.00%
Anika Therapeutics
Nov 6, 2025
Maintains: Outperform
Price Target: $15$16
Current: $9.39
Upside: +70.39%
Henry Schein
Nov 5, 2025
Maintains: Outperform
Price Target: $78$79
Current: $76.50
Upside: +3.27%
Orthofix Medical
Nov 5, 2025
Maintains: Outperform
Price Target: $17$18
Current: $14.99
Upside: +20.08%
Option Care Health
Oct 31, 2025
Maintains: Outperform
Price Target: $38
Current: $31.95
Upside: +18.94%
OPKO Health
Oct 30, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.31
Upside: +71.76%
U.S. Physical Therapy
Oct 24, 2025
Maintains: Outperform
Price Target: $103
Current: $80.00
Upside: +28.75%
LeMaitre Vascular
Oct 15, 2025
Maintains: Outperform
Price Target: $95
Current: $83.97
Upside: +13.14%
Maintains: Outperform
Price Target: $1.25$1.5
Current: $0.67
Upside: +123.18%
Downgrades: Market Perform
Price Target: n/a
Current: $8.05
Upside: -